{"id":80841,"date":"2025-05-07T03:40:14","date_gmt":"2025-05-07T03:40:14","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/80841\/"},"modified":"2025-05-07T03:40:14","modified_gmt":"2025-05-07T03:40:14","slug":"reportaid-grabs-e2-2m-to-solve-european-healthcare-data-challenge-boosting-hospital-revenue-by-25-tfn","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/80841\/","title":{"rendered":"ReportAId grabs \u20ac2.2M to solve European healthcare data challenge, boosting hospital revenue by 25% \u2014 TFN"},"content":{"rendered":"

Healthcare systems across Europe face a mounting challenge: despite massive investments in digital infrastructure, approximately 80% of healthcare data<\/a> remains unstructured, buried in clinical notes, imaging reports, and physician narratives. This fragmentation forces physicians to spend nearly half their time on administrative tasks instead of patient care. A recent survey revealed<\/a> that 93% of physicians experience burnout, with many logging an additional 15 hours of \u201cpyjama time\u201d \u2014 work completed after regular hours \u2014 each week.<\/p>\n

ReportAId, founded in Milan in 2024, tackles this inefficiency with an AI platform that automatically interprets medical reports and transforms them into interactive tools, guiding patients and clinicians through personalised care pathways.\u00a0<\/p>\n

The startup has secured \u20ac2.2 million in pre-seed funding to scale its solution, which is already showing significant impact at leading Italian healthcare institutions. The pre-seed funding round was led by Italian Founders Fund<\/a>, with participation from Heartfelt<\/a>, Exceptional Ventures, 2100 Ventures<\/a>, Vento<\/a>, Ithaca<\/a>, B Heroes<\/a>, Vesper Holding, and angel investors Luca Ascani, Enrico Giacomelli, Francesco Zaccariello, and Luca Foschini.<\/p>\n

This investment will enable ReportAId to hire ten new team members and expand across Italian and European healthcare, scaling a solution already deployed at leading institutions like San Raffaele Hospital and being adopted by Ospedale Isola Tiberina \u2013 Gemelli Isola.<\/p>\n

Turning unstructured medical reports into actionable care plans<\/p>\n

Founded in Milan in 2024 by Giuseppe Faraci<\/a> (CEO), Claudio Caletti<\/a> (CTO), and Luca Foresti<\/a> (Chairman), ReportAId uses artificial intelligence to optimise healthcare processes, automatically interpreting medical reports and converting them into interactive tools for providers and patients, while maintaining full compliance with European privacy regulations.<\/p>\n

At ReportAId\u2019s core is advanced natural language processing (NLP) technology that extracts critical insights from unstructured clinical documents. While traditional healthcare systems rely primarily on structured data, they fail to capture the full scope of patient information in narrative formats. ReportAId bridges this gap by automatically interpreting these complex documents and converting them into structured, actionable care plans.<\/p>\n

\u201cReportAId is the first operator to bring AI at scale into Italian healthcare. In the coming years, this technology will become a core pillar of the health system,\u201d said Giuseppe Faraci, CEO and co-founder of ReportAId. \u201cWe already work with leading private providers, but our goal is to support the public sector. We are ready for a concrete dialogue with local health directors, regional councillors and national ministries to help modernise the NHS.\u201d<\/p>\n

The platform creates comprehensive clinical databases from medical reports, giving healthcare facilities unprecedented insight into their operations and patient outcomes. This structured approach addresses healthcare\u2019s most persistent challenges \u2013 fragmented patient journeys that lead to missed follow-ups and readmissions. Research shows<\/a> that more than 20% of Medicare patients hospitalised for heart failure are readmitted within 30 days, highlighting the critical importance of effective follow-up systems.<\/p>\n

By applying AI to unstructured clinical data, ReportAId has created a solution that enhances patient experience while delivering significant operational benefits. Hospitals using the system report revenue increases of up to 25%. The company now aims to serve the public sector, making healthcare systems more efficient and accessible.<\/p>\n

How the ReportAId platform tackles the root causes of healthcare inefficiency\u00a0<\/p>\n

ReportAId transforms unstructured medical reports into organised databases and automated workflows while maintaining full EU privacy compliance. The platform\u2019s comprehensive clinical database gives healthcare facilities unprecedented insight into their operations and patient outcomes.<\/p>\n

The platform addresses healthcare\u2019s fundamental inefficiencies: poorly managed reports, fragmented care journeys, and complex treatment planning. Its AI-powered system extracts key data from medical documents and creates structured, personalised care plans that clarify next steps for everyone involved.<\/p>\n

For patients, this means streamlined access to their care pathway, simplifying appointment booking, medication purchases, and follow-up care. For providers, the platform enables efficient scheduling of tests and surgeries, developing therapeutic and preventive plans, and assessing prescription appropriateness according to clinical guidelines.<\/p>\n

While the healthcare AI sector has seen explosive growth, few solutions address the fundamental data structuring challenge that ReportAId tackles. With proven success at prestigious institutions like San Raffaele Hospital and a clear path to private and public sector adoption, the company is positioned to become a vital infrastructure layer in the European healthcare system.<\/p>\n

ReportAId\u2019s solution aligns perfectly with the European Union\u2019s ambitious European Health Data Space (EHDS) initiative, which aims to make health data more accessible for patient care and research. By 2029, the EHDS will enable<\/a> patients to access their digital health records across the EU, including electronic prescriptions and medical history summaries. ReportAId\u2019s strategic alignment with this initiative reassures stakeholders of the company\u2019s commitment to advancing healthcare in Europe.<\/p>\n

Plans? Scaling innovation across European healthcare<\/p>\n

Looking ahead, ReportAId plans to enhance its integration capabilities with existing healthcare IT systems, develop specialised AI capabilities for different medical disciplines, and collaborate with public healthcare authorities to implement its solution at scale. This will create a more efficient, accessible healthcare system that better serves patients while reducing costs and administrative burden.<\/p>\n

\u201cReportAId is one of the most tangible and transformative AI applications in healthcare. It tackles critical inefficiencies \u2013 from fragmented clinical data and gaps in patient management to structural waiting-list issues,\u201d said Irene Mingozzi<\/a>, Principal at Italian Founders Fund. \u201cBy turning medical reports into structured, automated actions, the platform directly improves continuity and quality of care. IFF seeks this impact: ambitious founders, enabling technology and a long-term vision to improve things. We also believe ReportAid\u2019s potential extends far beyond Italy.\u201d<\/p>\n

\u201cHealthcare is the perfect field for AI, and the founders \u2013 already well-known in the AI and health ecosystem \u2013 are attacking one of the sector\u2019s biggest inefficiencies with a simple, elegant and scalable solution,\u201d added Paolo Pio<\/a>, Co-Founder & General Partner at Exceptional Ventures. \u201cTraction in Italy is real, and demand is knocking. We\u2019re excited to join their mission.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Healthcare systems across Europe face a mounting challenge: despite massive investments in digital infrastructure, approximately 80% of healthcare…\n","protected":false},"author":2,"featured_media":80842,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[323,299,5036,105,4348,39265,12,16,15],"class_list":{"0":"post-80841","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-ai","9":"tag-europe","10":"tag-funding","11":"tag-health","12":"tag-healthcare","13":"tag-medtech","14":"tag-news","15":"tag-uk","16":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114464477933649066","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/80841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=80841"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/80841\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/80842"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=80841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=80841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=80841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}